| |
| |
|
| Insider
Information: |
Fong Bryant |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
83,941 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,423,639 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
83,941 |
|
|
| Total
Value |
$1,423,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 127.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neos Therapeutics, Inc. |
NEOS |
Director |
2021-03-19 |
0 |
2016-08-31 |
0 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
|
2024-02-26 |
83,941 |
2023-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMA |
ADMA Biologics Inc |
Director |
– • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
34,086 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
59,901 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2023-08-22 |
4 |
S |
$3.87 |
$5,544,737 |
I/I |
(1,433,304) |
0 |
0 |
% |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
83,941 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Director |
– • – |
2016-08-31 |
4 |
B |
$6.54 |
$9,810 |
D/D |
1,500 |
1,500 |
2.39 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
23,453 |
24,953 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Director |
– • – |
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,953) |
0 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
